Letter to the editor on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/ bevacizumab failure: A real-world study”

Author: Meng-Che WU ¹ ; Hui-Chin CHANG ; Yi-Sheng JHANG ; Shuo-Yan GAU
Author Information

1. Division of Pediatric Gastroenterology, Children’s Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan
Publication Type:Letter to the Editor
From:Clinical and Molecular Hepatology 2025;31(1):e13-e14
CountryRepublic of Korea
Language:English